Investor Relations

Press Releases

12/13/18
Conformis Announces Strategic Actions to Reach Profitability and Reduce Debt
Conformis Provides 2019 Cost & Debt Reduction Initiatives Optimize sales, marketing and administrative expense to take advantage of recently achieved gross margin & operational efficiencies Sharpen focus on new product development by prioritizing product segments with higher growth opportunities
10/31/18
Conformis Reports Third Quarter 2018 Financial Results and Updates Fiscal Year 2018 Guidance
BILLERICA, Mass. , Oct. 31, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique
10/10/18
Conformis to Host Third Quarter 2018 Financial Results Webcast on October 31, 2018
BILLERICA, Mass. , Oct. 10, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, October 31, 2018 , at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter 2018.  The webcast will be live at:
09/17/18
Conformis Announces Settlement of Patent Dispute with Smith & Nephew

Conformis to Receive $10.5 Million for Non-Exclusive License to Patient-Specific Instrument Patents for use with off-the-shelf knee implants BILLERICA, Mass. , Sept. 17, 2018 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit

08/02/18
Conformis announces election of Carrie Bienkowski to its Board of Directors

BILLERICA, Mass. , Aug. 02, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy,

08/01/18
Conformis Announces the first 3D Total Hip Replacement Surgeries performed at JFK Medical Center in Florida

The most advanced, patient conforming hip replacement system designed to enhance operational efficiency for the surgeon and improve patient outcomes BILLERICA, Mass., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that offers patient conforming joint

08/01/18
Conformis Reports Second Quarter 2018 Financial Results

BILLERICA, Mass. , Aug. 01, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient specific joint replacement implants designed to fit each patient's unique

07/12/18
Conformis to Host Second Quarter 2018 Financial Results Webcast on August 1, 2018

BILLERICA, Mass. , July 12, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it will host a webcast on Wednesday, August 1, 2018 , at 4:30 p.m. Eastern Time to discuss its financial results for the second quarter 2018.  The webcast will be live at:

06/25/18
Peer Reviewed Results: Conformis Patient Specific iTotal CR Achieves Better Rotational Alignment and Tibial Fit Compared to Off-the-Shelf Implants
Manuscript highlights the intraoperative compromises of fit vs. rotation with the legacy off-the-shelf knee implants BILLERICA, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to
05/02/18
Conformis Reports First Quarter 2018 Financial Results
BILLERICA, Mass. , May 02, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy,
04/12/18
Conformis to Host First Quarter 2018 Financial Results Conference Call and Webcast on May 2, 2018
BILLERICA, Mass. , April 12, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Wednesday, May 2, 2018 , at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter 2018.  To participate in the conference call, please
03/07/18
Four-Year Data from the UK National Joint Registry Highlights High Survivorship in Patients Treated with the Conformis iTotal CR
Data Shows a Low Cumulative Percent Revision of 0.5% for Conformis Patients vs 1.9% for all Total Knee Replacement Patients BILLERICA, Mass. , March 07, 2018 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants designed and
03/01/18
Conformis iTotal CR Knee Replacement System Awarded “3A” Rating from the Orthopaedic Data Evaluation Panel in the United Kingdom
Rating highlights positive three-year survivorship following total knee arthroplasty BILLERICA, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants designed and manufactured to fit and conform to each patient's
02/07/18
ConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial Guidance
BILLERICA, Mass. , Feb. 07, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy,
01/25/18
ConforMIS Announces Pricing of Public Offering of Common Stock
BILLERICA, Mass. , Jan. 25, 2018 (GLOBE NEWSWIRE) -- ConforMIS ,  Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique
01/24/18
ConforMIS Announces Proposed Public Offering of Common Stock
BILLERICA, Mass. , Jan. 24, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy,
01/08/18
ConforMIS Reports Preliminary Fourth Quarter and Year-End 2017 Revenue Results; Provides 2018 Financial Guidance
ConforMIS to Host Fourth Quarter and the Year Ended 2017 Financial Results Conference Call and Webcast on February 7, 2018 BILLERICA, Mass. , Jan. 08, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology
01/04/18
ConforMIS Announces Publication of Results published in the peer-reviewed Journal of Knee Surgery showing 100% of patients treated with iTotal CR achieve mechanical alignment in target range of +/- 3%
BILLERICA, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants designed and manufactured to fit each patient’s unique anatomy, today announced the publication of a prospective study in The Journal of Knee